GENERALIZED PUSTULAR PSORIASIS

This study tested whether a single intravenous dose of an experimental drug called spesolimab could quickly treat severe, sudden flares of generalized pustular psoriasis (GPP). It compared spesolimab to a placebo in 53 adult patients experiencing a moderate-to-severe flare. The m…

This program provided early access to an intravenous drug called spesolimab for adults in China suffering from severe, sudden flare-ups of Generalized Pustular Psoriasis (GPP), a rare and serious skin disease. It was for patients who had no other satisfactory treatment options av…

This study tested whether a medication called imsidolimab (ANB019) could help adults with severe generalized pustular psoriasis, a rare and painful skin condition. Eight participants received the drug to see if it reduced their skin lesions, pustules, and other symptoms. Research…

This study tested whether the drug imsidolimab could help adults with generalized pustular psoriasis, a rare and severe skin condition that causes painful pus-filled bumps. Researchers compared the drug against a placebo in 45 participants to see if it could clear or nearly clear…

This study tested whether a medicine called spesolimab, given as a monthly injection, could prevent painful and serious skin flare-ups in people with a history of generalized pustular psoriasis (GPP). About 123 adolescents and adults whose skin was currently clear received either…

This study monitored patients in Japan who were newly prescribed the intravenous drug spesolimab for severe flare-ups of generalized pustular psoriasis (GPP). The main goal was to track any side effects that occurred in a real-world setting, outside of a controlled clinical trial…